OBJECTIVE: To evaluate the effect of a pilot pharmaceutical care program developed for elderly patients with uncontrolled hypertension. METHODS: Nonrandomized single intervention pre/posttest blood pressure study in a community pharmacy in Aracaju, Brazil. This study enrolled elderly patients diagnosed with essential hypertension and uncontrolled blood pressure. Monthly visits were scheduled during a 10-month period. Pharmaceutical interventions were focused on health education and monitoring of drug-related problems. Primary outcomes included target blood pressure control, reduction in blood pressure, pulse pressure, medication adherence, and reduction of anthropometric indices. RESULTS: 35 of 51 patients completed the study. After 10 months of intervention, 57.2% of elderly patients achieved blood pressure control (P = 0.000) and the mean reduction was 26.6 mm Hg (P < 0.0001) for systolic blood pressure, 10.4 mm Hg (P < 0.0001) for diastolic blood pressure, and 15.7 mm Hg (P < 0.0001) for pulse pressure. Medication adherence also improved (P = 0.0000); however, anthropometric indices remained unchanged. CONCLUSION: The pharmaceutical care program improved outcomes by reducing and controlling blood pressure and improving medication adherence among elderly patients with uncontrolled hypertension.
OBJECTIVE: To evaluate the effect of a pilot pharmaceutical care program developed for elderly patients with uncontrolled hypertension. METHODS: Nonrandomized single intervention pre/posttest blood pressure study in a community pharmacy in Aracaju, Brazil. This study enrolled elderly patients diagnosed with essential hypertension and uncontrolled blood pressure. Monthly visits were scheduled during a 10-month period. Pharmaceutical interventions were focused on health education and monitoring of drug-related problems. Primary outcomes included target blood pressure control, reduction in blood pressure, pulse pressure, medication adherence, and reduction of anthropometric indices. RESULTS: 35 of 51 patients completed the study. After 10 months of intervention, 57.2% of elderly patients achieved blood pressure control (P = 0.000) and the mean reduction was 26.6 mm Hg (P < 0.0001) for systolic blood pressure, 10.4 mm Hg (P < 0.0001) for diastolic blood pressure, and 15.7 mm Hg (P < 0.0001) for pulse pressure. Medication adherence also improved (P = 0.0000); however, anthropometric indices remained unchanged. CONCLUSION: The pharmaceutical care program improved outcomes by reducing and controlling blood pressure and improving medication adherence among elderly patients with uncontrolled hypertension.
Authors: Beatriz Maria Pereira Girolineto; Alan Maicon de Oliveira; Ana Maria Rosa Freato Gonçalves; Marília Silveira de Almeida Campos; Leonardo Régis Leira Pereira Journal: Einstein (Sao Paulo) Date: 2019-12-13
Authors: Andrea Torres-Robles; Shalom I Benrimoj; Miguel Angel Gastelurrutia; Fernando Martinez-Martinez; Tamara Peiro; Beatriz Perez-Escamilla; Kris Rogers; Isabel Valverde-Merino; Raquel Varas-Doval; Victoria Garcia-Cardenas Journal: BMJ Qual Saf Date: 2021-03-29 Impact factor: 7.035
Authors: Peter Joseph Jongen; Evert Sanders; Cees Zwanikken; Jan Koeman; Leo H Visser; Petra Koopmans; Dirk Lehnick Journal: Patient Prefer Adherence Date: 2013-04-09 Impact factor: 2.711